Using technology creatively to help as many people as possible live longer, healthier, and happier lives,
while minimizing unnecessary healthcare costs.
this is both the desire and goal of M3.
Investor Relations
2026/11/04
Investor Relations
[FY2026 Q2] Summary of Consolidated Financial Results
2026/11/04
Investor Relations
[FY2026 Q2] M3 Presentation Material
2026/11/04
Investor Relations
An Investor Report "M3 Report for Investors 2026"
2026/11/02
Investor Relations
Notice Regarding the Status of Repurchase of Own Shares (Repurchase of Shares Under the Provision of M3’s Articles of Incorporation Pursuant to Article 459, Paragraph 1 of the Companies Act)
2026/10/01
Investor Relations
Notice Regarding the Status of Repurchase of Own Shares (Repurchase of Shares Under the Provision of M3’s Articles of Incorporation Pursuant to Article 459, Paragraph 1 of the Companies Act)
2026/09/01
Investor Relations
Notice Regarding the Status of Repurchase of Own Shares (Repurchase of Shares Under the Provision of M3’s Articles of Incorporation Pursuant to Article 459, Paragraph 1 of the Companies Act)
2026/08/21
Investor Relations
Notice Concerning Determination of the Terms of Issuance of Stock Options (Share Acquisition Rights)
2026/08/06
Investor Relations
[FY2026 Q1] Summary of Consolidated Financial Results
2026/08/06
Investor Relations
[FY2026 Q1] M3 Presentation Material
2026/08/06
Investor Relations
Notice Concerning Grant of Stock Options (Share Acquisition Rights)
